Regentis Biomaterials

Israeli hydrogel implant developer Regentis Biomaterials prices US IPO at $8, below the range   Regentis Biomaterials, an Israeli regenerative medicine company developing orthopedic hydrogel implants, raised $10 million by offering 1.3 million shares at $8, below the range of... Read more